Overview

Optimal Volume of Bupivacaine in Adductor Canal Nerve Block

Status:
Unknown status
Trial end date:
2017-03-01
Target enrollment:
Participant gender:
Summary
To establish adequate volume of levobupivacaine 0.25% in adductor canal nerve block in unilateral cruciate ligament of the knee reconstruction surgery.
Phase:
Phase 4
Details
Lead Sponsor:
Pontificia Universidad Catolica de Chile
Treatments:
Bupivacaine
Levobupivacaine